Professional Documents
Culture Documents
Efek Bayi Kurang Gizi
Efek Bayi Kurang Gizi
January
VOLUME 56
NUMBER 1
Original Article
Abstract
Background The problems of stunting are its high prevalence as
well as the complexity of its risk factors. Identifying the modifiable
prognostic factors at birth may reduce the shortterm as well as
longterm effects of stunting in later life.
Objective To estimate the influence of prognostic factors detected
at birth for stunting at 24 months of age and the occurence of
reversal of stunting at 24 months of age among children in a rural
area of Indonesia.
Methods Subjects (n=343) were born to mothers participating
in a randomized controlled, double-blind, community-based study
of vitamin A and/or zinc supplementation during pregnancy and
followed from June 1998 to October 2000. The children were
followed prospectively from birth until 2 years of age with monthly
measurements of length from birth to 12 months, and again at 18
and 24 months. Data on potential prognostic factors detected at
birth, i.e., maternal, child, and household facilities, were collected
by trained field workers at home visits. The incidence and risk ratio
were calculated to assess the influence of the possible prognostic
factors detected at birth on stunting at 24 months of age among
these children.
Results Boys who were born prematurely had significantly
higher risk of stunting at 24 months of age compared to girls born
maturely. The incidences of stunting at 24 months of age according
WRJHQGHUDQGJHVWDWLRQDODJHZHUHER\Vvs.JLUOV
55&,WRDQGSUHPDWXUHvs.
PDWXUH55&,WRUHVSHFWLYHO\
Conclusion Boys who were born prematurely have significantly
higher risk to become stunted at 24 months of age. The occurrence
of reversal of stunting at 24 months of age is low. [Paediatr
Indones. 2016;56:48-56.].
Keywords: stunting, 24 months, prognostic factors
Endy P. Prawirohartono et al: Prognostic factors at birth for stunting at 24 months of age
Methods
We analyzed secondary data from the Zibuvita and
the Pronak Studies done from September 1995 to
December 1999 in the Purworejo District, Central
Java, Indonesia. The Zibuvita Study was a communitybased, double-blind, randomized controlled trial to
evaluate the effects of prenatal vitamin A and zinc
on maternal morbidity and pregnancy outcomes.
Infants born to Zibuvita mothers (without congenital
anomalies) whose mothers consented to participate
were included in the Pronak Study, a longitudinal
study monitoring children from birth onwards with
respect to growth, development, feeding practices, and
morbidity. The results of these studies were published
elsewhere.26,27
We had an opportunity to analyze data from 343
infants who had complete or at least minimally missing
Endy P. Prawirohartono et al: Prognostic factors at birth for stunting at 24 months of age
Results
Out of 1,956 infants born live to Zibuvita mothers,
1,613 infants were excluded due to lack of maternal
consent, being in another study involving micronutrient
supplementation (namely, the Zinak Study), or who
had missing body length data which could not be
imputed.
Of 343 children, the prevalence of stunting at
ELUWKZDV/DWHULQOLIH
children became stunted between the age of 0 and 24
PRQWKV$WPRQWKVRIDJHFKLOGUHQ
were still stunted. However, of the 121 children who
ZHUHVWXQWHGEHWZHHQPRQWKVRIDJH
children were no longer stunted at 24 months of age
(Figure 1).
Table 1 shows that the majority of mothers in our
VWXG\KDGDORZHGXFDWLRQDOOHYHO3UHPDWXULW\
DQGVPDOOIRUJHVWDWLRQDODJHRFFXUUHGLQDQG
RI WKH VXEMHFWV UHVSHFWLYHO\ 2QO\ RI
household facilities had unimproved water sources.
We compared children who were not stunted at 24
months of age to children who were stunted at 24
months of age, to evaluate the potential prognostic
factors related to stunting at 24 months of age. Table
2 shows that gender and gestational age correlated
to stunting at 24 months of age. The incidences of
stunting at 24 months of age were higher in boys
FRPSDUHGWRJLUOVvs.DQGSUHPDWXULW\
FRPSDUHG WR PDWXULW\ vs. +HQFH
LQIDQWVRIPDOHJHQGHU55&,WR
DQGSUHPDWXULW\55&,WRKDG
higher risk of stunting at 24 months of age compared
to infants of female gender and normal gestational
age.
$OWKRXJKRIFKLOGUHQZKRZHUHVWXQWHG
sometime between 0-24 months of age were no longer
stunted at 24 months, we could not determine that
the proportion of reversal of stunting in our study was
%DVHG RQ RXU GHILQLWLRQ RQO\
experienced reversal of stunting at 24 months of age.
Birth characteristics of 3 children who experienced
reversal of stunting at 24 months of age were as
follows: mature, not stunted at birth, appropriate-
Endy P. Prawirohartono et al: Prognostic factors at birth for stunting at 24 months of age
Stunted at 24 months
(n = 96)
No reversal of stunting
(n = 22)
Reversal of stunting
(n = 3)
Figure 15VWF[RTQNG
Discussion
Our multivariable analysis of factors identifiable at
birth revealed that male gender and premature birth
were significant prognostic factors of stunting at
24 months of age. Few children who had ever been
stunted in the period of 24 months of life experienced
reversal of stunting at 24 months of age.
Previous studies from African countries,
Cambodia, India, and Brazil also reported male
gender to be a predictor of stunting.13-16,29 A metaanalysis of 16 demographic and health surveys from
Sub-Saharan Africa observed that boys were more
Endy P. Prawirohartono et al: Prognostic factors at birth for stunting at 24 months of age
Table 1.$CUKEEJCTCEVGTKUVKEUQHOQVJGTUCPFEJKNFTGPCEEQTFKPIVQUVWPVKPIUVCVWUHTQOCNQPIKVWFKPCNUVWF[
%JCTCEVGTKUVKEU
/QVJGT
*GKIJVEOP
+NNKVGTCVGNQYGFWECVKQPCNNGXGNP
%JKNF
(GOCNGIGPFGTP
(KTUVDQTPP
2TGOCVWTGP
5OCNNHQTIGUVCVKQPCNCIGP
5VWPVKPICVDKTVJP
*QWUGJQNFHCEKNKVKGU
7PKORTQXGFYCVGTUQWTEGUP
7PKORTQXGFUCPKVCVKQPP
2TQRQTVKQPQHVQVCN
5VWPVKPIUVCVWUQHVJGEJKNFTGPFWTKPIVJG
TUVOQQHNKHG
5VWPVKPI
0QUVWPVKPI
P
P
UVWPVKPI*#<5&QH9*1)TQYVJ5VCPFCTF
PGXGTCVVGPFGFUEJQQNQTWRVQRTKOCT[UEJQQNITCFWCVG
IGUVCVKQPCNYGGMU
DKTVJYGKIJVVJRGTEGPVKNG
CEEQTFKPIVQ9*1ETKVGTKC
Endy P. Prawirohartono et al: Prognostic factors at birth for stunting at 24 months of age
Table 2+PEKFGPEGUQHUVWPVKPICPFTKUMHQTUVWPVKPICVOQPVJUQHCIGD[RTQIPQUVKEHCEVQTUKFGPVKGFCVDKTVJ
OCVGTPCN
EJKNFCPFJQWUGJQNFHCEVQTU
2TGFKEVKXGHCEVQTU
/CVGTPCNHCEVQTU
/CVGTPCNJGKIJV
EO
/CVGTPCNGFWECVKQP
*KIJGFWECVKQPCNNGXGN
+NNKVGTCVGNQYGFWECVKQPCNNGXGN
%JKNFHCEVQTU
)GPFGT
(GOCNG
/CNG
)GUVCVKQPCVDKTVJ
/CVWTG
2TGOCVWTG
5K\GHQTIGUVCVKQPCNCIG
#RRTQRTKCVGHQTIGUVCVKQPCNCIG
5OCNNHQTIGUVCVKQPCNCIG
$KTVJYGKIJV
0QTOCN
.QY
$KTVJQTFGT
0QVTUVDQTP
(KTUVDQTP
*QWUGJQNFHCEVQTU
9CVGTUQWTEGU
+ORTQXGF
7PKORTQXGF
5CPKVCVKQPHCEKNKVKGU
+ORTQXGF
7PKORTQXGF
+PEKFGPEG
RR
7PCFLWUVGFTKUM
%+
33.9
1.68
VQ
22.0
30.1
1
VQ
33.9
1
VQ
27.6
33.3
1
VQ
26.8
1
3.96
VQ
26.0
1
8.08
VQ
26.9
31.9
1
1.26
VQ
27.9
30.2
1
1.10
VQ
26.8
29.8
1
1.38
VQ
2XCNWG
0.12
0.19
0.001
0.007
<0.001
RR
#FLWUVGFTKUM
%+
VQ
1
VQ
1
1.80
VQ
1
7.11
VQ
1
3.32
VQ
1
VQ
1
1.17
VQ
0.78
0.16
PGXGTCVVGPFGFUEJQQNWRVQRTKOCT[UEJQQNITCFWCVG
DKTVJYGKIJVVJRGTEGPVKNG
CEEQTFKPIVQ9*1ETKVGTKC
RTQIPQUVKEHCEVQTUYKVJ2YGTGKPENWFGFKPOWNVKXCTKCVGCPCN[UKU
UKIPKECPV
Endy P. Prawirohartono et al: Prognostic factors at birth for stunting at 24 months of age
Conflict of interest
None declared.
References
1.
2.
3.
4.
5.
6.
7.
Endy P. Prawirohartono et al: Prognostic factors at birth for stunting at 24 months of age
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Endy P. Prawirohartono et al: Prognostic factors at birth for stunting at 24 months of age
33. Barker DJ. The developmental origins of insulin resistance.
Horm Res. 2005;64:27.
34. Leitch I. Growth and health. 1951. Int J Epidemiol.
2001;30:212-6.
35. Barker DJ. The developmental origins of insulin resistance.
Horm Res. 2005;64:27.